Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

38.45
Delayed Data
As of Feb 22
 +0.35 / +0.92%
Today’s Change
24.65
Today|||52-Week Range
50.05
-3.51%
Year-to-Date
No recent news for Supernus Pharmaceuticals Inc.

Today’s Trading

Previous close38.10
Today’s open38.30
Day’s range37.80 - 39.00
Volume354,129
Average volume (3 months)546,592
Market cap$2.0B
Data as of 4:00pm ET, 02/22/2018

Growth & Valuation

Earnings growth (last year)+528.57%
Earnings growth (this year)-38.42%
Earnings growth (next 5 years)+27.00%
Revenue growth (last year)+48.87%
P/E ratio35.0
Price/Sales6.07
Price/Book9.93

Competitors

 Today’s
change
Today’s
% change
PRTAProthena Corporation...+0.55+1.66%
HZNPHorizon Pharma PLC-0.13-0.92%
FOLDAmicus Therapeutics ...-0.04-0.26%
AXONAxovant Sciences Ltd+0.01+0.62%
Data as of 4:00pm ET, 02/22/2018

Financials

Last reporting date--
EPS forecast (this quarter)$0.28
Annual revenue (last year)$215.0M
Annual profit (last year)$91.2M
Net profit margin42.43%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Secretary &
Director
Jack A. Khattar
Chief Financial Officer &
Vice President
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts